In The Press.
A Feasibility Study to Evaluate Safety and Probable Benefit
Revolutionizing Treatment for Short Bowel Syndrome with Dr. James Dunn
Medtech Startup Eclipse Regenesis Offers Hope to Young Patient with Short Bowel Syndrome
Eclipse Regenesis Reaches First-in-Human Milestone with Treatment for Short Bowel Syndrome
CTIP Accelerator Announces 2022 Winners for Catalyzing Pediatric Innovation Annual Grant Competition
Novel Device Uses Mechanotransduction To Treat Small Bowel Syndrome
Eclipse Regenesis Awarded National Institutes of Health (NIH) Grant
Fogarty Company Pursues A Therapy That Eclipses All Others to Treat a Devastating Pediatric Syndrome
Mechanical Treatment for Short Bowel Syndrome
Pediatric Device Showcase: Eclipse Regenesis
MedTech Innovator Announces Top 15 Startups Selected for Pediatric Accelerator Program
Virtual Pitch Competition Recognizes Pediatric Device Innovators
Healing from Within Starts Here
We believe the future of gastrointestinal care is regenerative, not restrictive. With the Eclipse XL1, we’re working to give patients the chance to grow what was once gone, and to live fuller, more independent lives.